Women’s Health

Women’s Health

Breast cancer screening program
KCS’ Women’s Health Program aspires to eliminate the health disparities among Korean-American and other minority immigrant women by offering culturally competent patient navigation services. Since the start of the project in 2007, the Women’s Health initiative has been providing no-cost mammography screenings, Clinical Breast Exams (CBE), and referrals for uninsured or undercovered immigrant women to cervical and colorectal cancer screenings. KCS is only the Korean-
American community based organization that operates an on-site mobile breast cancer screening every month throughout NYC’s 5 boroughs. Additionally, we actively conduct a small educational workshop relating to women’s health issues. The service promotes cancer preventive care and screening by increasing awareness of breast cancer and addressing language and cultural barriers.

No-cost mammogram screenings
Eligibility Requirements:
· NYC resident women
· Women aged 40 or older, with or without the insurance
· Women who have not received a free mammogram in the past year
· Undocumented and refugee status women can also get the screening
· No pregnant or breastfeeding women will receive a mammogram

Education for Breast Cancer Prevention
“A culturally tailored education program to reduce breast cancer risk in Korean immigrant women.” KCS will partner with the Hunter College School of Nursing to promote the healthy
lifestyle to reduce breast cancer risk. The researchers, Jin Young Seo, Ph.D., and So-Hyun Park, Ph.D. received the grant from New York State Department of Health, a Patricia S. Brown Breast Cancer Risk Reduction Education research Projects. The purpose of this grant is to encourage the development and implementation of innovative pilot projects in breast cancer risk reduction education with the design of new educational strategies to elicit behavior changes intended to reduce specific risk factors associated with developing breast cancer. The approved award amount is $245,002 for the anticipated contract period of January 1, 2019, to December 31, 2021.